Characteristics of 807 CMV-seronegative SCT recipients
. | n . | % . |
---|---|---|
Transplant type | ||
Autologous | 242 | 30.0 |
Matched allogeneic | 230 | 28.5 |
Mismatched/unrelated allogeneic | 335 | 41.5 |
Underlying disease | ||
Acute leukemia | 223 | 27.6 |
CML | 205 | 25.4 |
Hodgkin disease/NHL | 83 | 10.3 |
Myelodysplasia | 82 | 10.2 |
Breast cancer | 76 | 9.4 |
Aplastic anemia/multiple myeloma/CLL | 51 | 6.3 |
Other | 87 | 10.8 |
Stem cell source | ||
Bone marrow | 477 | 59.1 |
Peripheral blood | 330 | 40.9 |
. | n . | % . |
---|---|---|
Transplant type | ||
Autologous | 242 | 30.0 |
Matched allogeneic | 230 | 28.5 |
Mismatched/unrelated allogeneic | 335 | 41.5 |
Underlying disease | ||
Acute leukemia | 223 | 27.6 |
CML | 205 | 25.4 |
Hodgkin disease/NHL | 83 | 10.3 |
Myelodysplasia | 82 | 10.2 |
Breast cancer | 76 | 9.4 |
Aplastic anemia/multiple myeloma/CLL | 51 | 6.3 |
Other | 87 | 10.8 |
Stem cell source | ||
Bone marrow | 477 | 59.1 |
Peripheral blood | 330 | 40.9 |
CMV indicates cytomegalovirus; SCT, stem cell transplant; CML, chronic myelogenous leukemia; NHL, non-Hodgkin lymphoma; CLL, chronic lymphocytic leukemia.